↓ Skip to main content

The role of human umbilical cord tissue-derived mesenchymal stromal cells (UCX®) in the treatment of inflammatory arthritis

Overview of attention for article published in Journal of Translational Medicine, January 2013
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (70th percentile)
  • Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

patent
1 patent
facebook
1 Facebook page

Citations

dimensions_citation
45 Dimensions

Readers on

mendeley
88 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The role of human umbilical cord tissue-derived mesenchymal stromal cells (UCX®) in the treatment of inflammatory arthritis
Published in
Journal of Translational Medicine, January 2013
DOI 10.1186/1479-5876-11-18
Pubmed ID
Authors

Jorge M Santos, Rita N Bárcia, Sandra I Simões, Manuela M Gaspar, Susana Calado, Ana Água-Doce, Sílvia CP Almeida, Joana Almeida, Mariana Filipe, Mariana Teixeira, José P Martins, Luís Graça, Maria EM Cruz, Pedro Cruz, Helder Cruz

Abstract

ECBio has developed proprietary technology to consistently isolate, expand and cryopreserve a well-characterized population of stromal cells from human umbilical cord tissue (UCX® cells). The technology has recently been optimized in order to become compliant with Advanced Medicine Therapeutic Products. In this work we report the immunosuppressive capacity of UCX® cells for treating induced autoimmune inflammatory arthritis.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 88 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 1%
United States 1 1%
Sri Lanka 1 1%
Ireland 1 1%
Unknown 84 95%

Demographic breakdown

Readers by professional status Count As %
Student > Master 19 22%
Researcher 18 20%
Student > Ph. D. Student 17 19%
Student > Doctoral Student 7 8%
Professor 4 5%
Other 14 16%
Unknown 9 10%
Readers by discipline Count As %
Agricultural and Biological Sciences 21 24%
Medicine and Dentistry 20 23%
Biochemistry, Genetics and Molecular Biology 9 10%
Pharmacology, Toxicology and Pharmaceutical Science 7 8%
Immunology and Microbiology 6 7%
Other 13 15%
Unknown 12 14%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 September 2019.
All research outputs
#7,209,728
of 22,789,076 outputs
Outputs from Journal of Translational Medicine
#1,156
of 3,988 outputs
Outputs of similar age
#82,077
of 284,957 outputs
Outputs of similar age from Journal of Translational Medicine
#27
of 84 outputs
Altmetric has tracked 22,789,076 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 3,988 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.5. This one has gotten more attention than average, scoring higher than 69% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 284,957 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 84 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.